Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4327-4332

  Schwint, O Nicolas ^a   Ueti, Massaro W ^a   Palmer, Guy H ^a   Kappmeyer, Lowell S ^b   Hines, Melissa T ^a   Cordes, R Timothy ^c   Knowles, Donald P ^a,b   Scoles, Glen A ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDOCARB DIPROPIONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BABESIA CABALLI; BLOOD TRANSFUSION; CONTROLLED STUDY; EQUINE PIROPLASMOSIS; FEMALE; HORSE; INFECTION CONTROL; INFECTION RISK; INFECTION SENSITIVITY; INOCULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE TRANSMISSION; PARASITE VIRULENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK REDUCTION; TICK BORNE DISEASE;

ANIMALS; ANTI-INFECTIVE AGENTS; BABESIA; BABESIOSIS; DISEASE TRANSMISSION, INFECTIOUS; HORSES; IMIDOCARB; TICKS;

EID: 70349304327     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00404-09     Document Type: Article

References (30)

1. Adams, L. G. 1981. Clinicopathological aspects of imidocarb dipropionate toxicity in horses. Res. Vet. Sci. 31:54-61.
2. Allred, D. R., and B. Al-Khedery. 2004. Antigenic variation and cytoadhesion in Babesia bovis and Plasmodium falciparum: different logics achieve the same goal. Mol. Biochem. Parasitol. 134:27-35.
3. Bose, R., and K. Daemen. 1992. Demonstration of the humoral immune response of horses to Babesia caballi by western blotting. Int. J. Parasitol. 22:627-630.
4. Brayton, K. A., A. O. Lau, D. R. Herndon, L. Hannick, L. S. Kappmeyer, S. J. Berens, S. L. Bidwell, W. C. Brown, J. Crabtree, D. Fadrosh, T. Feldblum, H. A. Forberger, B. J. Haas, J. M. Howell, H. Khouri, H. Koo, D. J. Mann, J. Norimine, I. T. Paulsen, D. Radune, Q. Ren, R. K. Smith, Jr., C. E. Suarez, O. White, J. R. Wortman, D. P. Knowles, Jr., T. F. McElwain, and V. M. Nene. 2007. Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa. PLoS Pathog. 3:1401-1413.
5. Bruning, A. 1996. Equine piroplasmosis: an update on diagnosis, treatment and prevention. Br. Vet. J. 152:139-151.
6. Butler, C. M., A. M. Nijhof, J. H. van der Kolk, O. B. de Haseth, A. Taoufik, F. Jongejan, and D. J. Houwers. 2008. Repeated high dose imidocarb dipropionate treatment did not eliminate Babesia caballi from naturally infected horses as determined by PCR-reverse line blot hybridization. Vet. Parasitol. 151:320-322.
7. Carbrey, E. A., R. J. Avery, R. C. Knowles, and S. C. Sash. 1971. Chemotherapy of equine babesiosis. J. Am. Vet. Med. Assoc. 159:1538-1545.
8. Delany-Moretlwe, S., J. R. Lingappa, and C. Celum. 2009. New insights on interactions between HIV-1 and HSV-2. Curr. Infect. Dis. Rep. 11:135-142.
9. de Waal, D. T. 1992. Equine piroplasmosis: a review. Br. Vet. J. 148:6-14.
10. Dolan, T. T. 1986. Chemotherapy of East Coast fever: the long term weight changes, carrier state and disease manifestations of parvaquone treated cattle. J. Comp. Pathol. 96:137-146.
11. Ewing, S. A., R. J. Panciera, and J. S. Mathew. 2003. Persistence of Hepatozoon americanum (Apicomplexa: Adeleorina) in a naturally infected dog. J. Parasitol. 89:611-613.
12. Frerichs, W. M., and A. A. Holbrook. 1974. Treatment of equine piroplasmosis (B caballi) with imidocarb dipropionate. Vet. Rec. 95:188-189.
13. Frerichs, W. M., A. A. Holbrook, and A. J. Johnson. 1969. Equine piroplasmosis: complement-fixation titers of horses infected with Babesia caballi. Am. J. Vet. Res. 30:697-702.
14. Friedhoff, K. T., A. M. Tenter, and I. Muller. 1990. Haemoparasites of equines: impact on international trade of horses. Rev. Sci. Tech. 9:1187-1194.
15. Futse, J. E., K. A. Brayton, D. P. Knowles, Jr., and G. H. Palmer. 2005. Structural basis for segmental gene conversion in generation of Anaplasma marginale outer membrane protein variants. Mol. Microbiol. 57:212-221.
16. Goff, W. L., K. I. O'Rourke, W. C. Johnson, P. A. Lacy, W. C. Davis, and C. R. Wyatt. 1998. The role of IL-10 in iNOS and cytokine mRNA expression during in vitro differentiation of bovine mononuclear phagocytes. J. Interferon Cytokine Res. 18:139-149.
17. Hodzic, E., S. Feng, K. Holden, K. J. Freet, and S. W. Barthold. 2008. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob. Agents Chemother. 52:1728-1736.
18. Holman, P. J., W. M. Frerichs, L. Chieves, and G. G. Wagner. 1993. Culture confirmation of the carrier status of Babesia caballi-infected horses. J. Clin. Microbiol. 31:698-701.
19. Howell, J. M., M. W. Ueti, G. H. Palmer, G. A. Scoles, and D. P. Knowles. 2007. Persistently infected calves as reservoirs for acquisition and transovarial transmission of Babesia bovis by Rhipicephalus (Boophilus) microplus. J. Clin. Microbiol. 45:3155-3159. (Pubitemid 47585634)
20. Kappmeyer, L. S., L. E. Perryman, S. A. Hines, T. V. Baszler, J. B. Katz, S. G. Hennager, and D. P. Knowles. 1999. Detection of equine antibodies to Babesia caballi by recombinant B. caballi rhoptry-associated protein 1 in a competitive-inhibition enzyme-linked immunosorbent assay. J. Clin. Microbiol. 37:2285-2290.
21. Knowles, D. P., Jr. 1996. Control of Babesia equi parasitemia. Parasitol. Today 12:195-198.
22. Knowles, D. P., Jr., L. S. Kappmeyer, D. Stiller, S. G. Hennager, and L. E. Perryman. 1992. Antibody to a recombinant merozoite protein epitope identifies horses infected with Babesia equi. J. Clin. Microbiol. 30:3122-3126.
23. Krause, P. J., B. E. Gewurz, D. Hill, F. M. Marty, E. Vannier, I. M. Foppa, R. R. Furman, E. Neuhaus, G. Skowron, S. Gupta, C. McCalla, E. L. Pesanti, M. Young, D. Heiman, G. Hsue, J. A. Gelfand, G. P. Wormser, J. Dickason, F. J. Bia, B. Hartman, S. R. Telford III, D. Christianson, K. Dardick, M. Coleman, J. E. Girotto, and A. Spielman. 2008. Persistent and relapsing babesiosis in immunocompromised patients. Clin. Infect. Dis. 46:370-376.
24. Krause, P. J., A. Spielman, S. R. Telford III, V. K. Sikand, K. McKay, D. Christianson, R. J. Pollack, P. Brassard, J. Magera, R. Ryan, and D. H. Persing. 1998. Persistent parasitemia after acute babesiosis. N. Engl. J. Med. 339:160-165.
25. Menge, D. M., K. C. Ernst, J. M. Vulule, P. A. Zimmerman, H. Guo, and C. C. John. 2008. Microscopy underestimates the frequency of Plasmodium falciparum infection in symptomatic individuals in a low transmission highland area. Am. J. Trop. Med. Hyg. 79:173-177.
26. Schwint, O. N., D. P. Knowles, M. W. Ueti, L. S. Kappmeyer, and G. A. Scoles. 2008. Transmission of Babesia caballi by Dermacentor nitens (Acari: Ixodidae) is restricted to one generation in the absence of alimentary reinfection on a susceptible equine host. J. Med. Entomol. 45:1152-1155.
27. Thompson, K. C., R. A. Todorovic, G. Mateus, and L. G. Adams. 1978. Methods to improve the health of cattle in the tropics: conclusions and economic appraisal. Trop. Anim. Health Prod. 10:141-144.
28. Ueti, M. W., G. H. Palmer, G. A. Scoles, L. S. Kappmeyer, and D. P. Knowles. 2008. Persistently infected horses are reservoirs for intrastadial tick-borne transmission of the apicomplexan parasite Babesia equi. Infect. Immun. 76:3525-3529.
29. Vial, H. J., and A. Gorenflot. 2006. Chemotherapy against babesiosis. Vet. Parasitol. 138:147-160.
30. Wilson, W. D., J. E. Mihalyi, S. Hussey, and D. P. Lunn. 2001. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet. J. 33:644-650.